Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Who got what and why? NMAC’s Paul Kawata addresses criticism and breaks down the data.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
ViiV Healthcare has given
about $6 million to 99 projects in 26 countries to improve the health of women,
children and families affected by...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.